Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

10.15
Delayed Data
As of 3:59pm ET
 -1.39 / -12.05%
Today’s Change
4.04
Today|||52-Week Range
11.91
+21.27%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close11.54
Today’s open10.60
Day’s range9.54 - 10.61
Volume3,403,415
Average volume (3 months)949,919
Market cap$335.0M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)-30.78%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+7.83%
P/E ratioNM
Price/Sales110.08
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
CNCEConcert Pharmaceutic...-0.10-0.68%
AQXPAquinox Pharmaceutic...+0.38+2.59%
SVASinovac Biotech Ltd-0.02-0.35%
NERVMinerva Neuroscience...-0.05-0.52%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$1.9M
Annual profit (last year)-$44.7M
Net profit margin-2,369.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Accounting &
Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts